CSF monoamine metabolites in schizophrenic patients
- 1 November 1982
- journal article
- research article
- Published by Wiley in Acta Psychiatrica Scandinavica
- Vol. 66 (5) , 350-360
- https://doi.org/10.1111/j.1600-0447.1982.tb06717.x
Abstract
The monoamine metabolites 3-methoxy-4-hydroxyphenylglycol (MHPG), homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5-HIAA) were measured in the cerebrospinal fluid (CSF) of 16 psychiatrically healthy controls and in 28 schizophrenic patients. There was no difference in CSF MHPG and HVA levels between the group of patients and the controls. CSF levels of 5-HIAA were significantly lower in schizophrenic patients than in controls. Differential analysis of patients with and without neuroleptics revealed that these findings were not due to drug treatment. Positive correlations were found between the level of 5-HIAA and the items: hallucinatory behaviour, grandiosity, and tension as rated on the Brief Psychiatric Rating Scale. As 5-HIAA CSF data are controversial for nosological entities, the search for correlations between 5-HIAA and individual psychopathological variables could provide more specific indices for psychiatric diagnosis, treatment or prophylaxis.Keywords
This publication has 35 references indexed in Scilit:
- Correlation of individual symptoms and other clinical variables with cerebrospinal fluid amine metabolites and tryptophan in depressionArchiv Fur Psychiatrie Und Nervenkrankheiten, 1981
- Low platelet MAO activity and schizophrenia: sex differencesActa Psychiatrica Scandinavica, 1981
- Platelet Monoamine Oxidase Activity in Acute Schizophrenia: Relationship to Symptomatology and Neuroleptic MedicationThe British Journal of Psychiatry, 1981
- Effect of chlorpromazine treatment on monoamine metabolite levels in cerebrospinal fluid of psychotic patientsActa Psychiatrica Scandinavica, 1977
- Precursors and metabolites of 5-hydroxytryptamine and dopamine in the ventricular cerebrospinal fluid of psychiatric patientsPsychological Medicine, 1976
- Clinical and Biochemical Parameters during Neuroleptic Treatment I. Investigations with HaloperidolPharmacopsychiatry, 1976
- Cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in psychiatric patientsInternational Journal of Neuropharmacology, 1969
- Acid Metabolites from Monoamines in Cerebrospinal Fluid of Chronic SchizophrenicsThe British Journal of Psychiatry, 1969
- 5-HYDROXYINDOLE COMPOUNDS IN THE CEREBROSPINAL FLUID OF PATIENTS WITH PSYCHIATRIC OR NEUROLOGICAL DISEASESThe Lancet, 1966
- Studies on sodium transfer and 5-hydroxyindoles in depressive illnessJournal of Neurology, Neurosurgery & Psychiatry, 1963